ArticleEClinicalMedicine2025

Safety and efficacy of neoadjuvant toripalimab plus chemotherapy followed by chemoradiotherapy for locally advanced esophageal squamous cell carcinoma in China (GASTO 1071): a non-randomised, two-cohort, phase 2 trial.

FangJie Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.